Next Article in Journal
Quality Control of Metaxa Cognac
Previous Article in Journal
Regression Linear Model of Air Pollution Emission on the Example of a Waste Incineration Plant
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Proceedings
Volume 55
Issue 1
10.3390/proceedings2020055014
proceedings-logo
Submit to this Journal
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Validation of a Screening Method Based on a Needle Stochastic Sensor for the Determination of Interleukins 1β, 6, and 12 in Biological Samples †

by
Sorin Sebastian Gheorghe
1,*,
Ruxandra Maria Ilie-Mihai
2,
Raluca-Ioana Stefan-van Staden
1,2 and
Alexandru Bratei
1,2
1
Faculty of Applied Chemistry and Material Science, University Politehnica of Bucharest, Bucharest 060021, Romania
2
Laboratory of Electrochemistry and PATLAB, National Institute of Research for Electrochemistry and Condensed Matter, Bucharest 060021, Romania
*
Author to whom correspondence should be addressed.
†
Presented at the Virtual Eurachem Workshop 2020—“Quality Assurance for Analytical Laboratories in the University Curriculum”, 14–15 July 2020; Available online: https://eurachem2020.ro/.
Proceedings 2020, 55(1), 14; https://doi.org/10.3390/proceedings2020055014
Published: 10 October 2020
(This article belongs to the Proceedings of The Virtual Eurachem Workshop 2020—“Quality Assurance for Analytical Laboratories in the University Curriculum”)
Versions Notes

Abstract

:
Interleukins proved to be valuable biomarkers for different diseases. Interleukins 1β, 6, and 12 can be used as biomarkers for brain cancer diagnosis, and therefore this paper proposed a needle stochastic sensor based on protoporphyrin IX immobilized in nano-diamond paste for fast screening of biological samples, such as whole blood, urine and brain tumoral tissue, for these interleukins. The results obtained using this needle stochastic sensor proved that the interleukins 1β, 6, and 12 can be reliably determined from whole blood, urine and brain tumoral tissue, with recoveries higher than 96.00% and with relative standard deviations lower than 1.00%. The validation of the method was performed using whole blood and tissue samples collected from the patients confirmed with brain tumor.

Conflicts of Interest

The author declares no conflict of interest.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Gheorghe, S.S.; Ilie-Mihai, R.M.; Stefan-van Staden, R.-I.; Bratei, A. Validation of a Screening Method Based on a Needle Stochastic Sensor for the Determination of Interleukins 1β, 6, and 12 in Biological Samples. Proceedings 2020, 55, 14. https://doi.org/10.3390/proceedings2020055014

AMA Style

Gheorghe SS, Ilie-Mihai RM, Stefan-van Staden R-I, Bratei A. Validation of a Screening Method Based on a Needle Stochastic Sensor for the Determination of Interleukins 1β, 6, and 12 in Biological Samples. Proceedings. 2020; 55(1):14. https://doi.org/10.3390/proceedings2020055014

Chicago/Turabian Style

Gheorghe, Sorin Sebastian, Ruxandra Maria Ilie-Mihai, Raluca-Ioana Stefan-van Staden, and Alexandru Bratei. 2020. "Validation of a Screening Method Based on a Needle Stochastic Sensor for the Determination of Interleukins 1β, 6, and 12 in Biological Samples" Proceedings 55, no. 1: 14. https://doi.org/10.3390/proceedings2020055014

Article Metrics

Back to TopTop